%0 Journal Article
%T JAK2/IDH-mutant¨Cdriven myeloproliferative neoplasm is sensitive to combined targeted inhibition
%A Alan H. Shih
%A Allison N. Lau
%A Amritha Varshini Hanasoge Somasundara
%A Andrew M. Intlekofer
%A Anna Sophia McKenney
%A April Chiu
%A Barbara Spitzer
%A Craig B. Thompson
%A Efthymia Papalexi
%A Elizaveta Freinkman
%A Esra A. Akbay
%A Franck T. Rapaport
%A Jihae Ahn
%A Julie Teruya-Feldstein
%A Kaitlyn Shank
%A Katharine Yen
%A Kwok-Kin Wong
%A Matthew G. Ver Heiden
%A Minal A. Patel
%A Mya Steadman
%A Raajit Rampal
%A Raj Nagaraja
%A Ross L. Levine
%J The Journal of Clinical Investigation
%D 2018
%R 10.1172/JCI124920
%U https://www.jci.org/articles/view/124920